These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33168156)

  • 1. Analysis of adjuvant chemotherapy in patients undergoing curative-intent resection of localized adrenocortical carcinoma.
    Al Asadi A; Hubbs DM; Sweigert PJ; Baker MS; Kabaker AS
    Am J Surg; 2021 Jul; 222(1):119-125. PubMed ID: 33168156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparate Practice Patterns and Survival Outcomes: The Impact of Centralization of Cancer Care for Adrenocortical Carcinoma in the United States.
    Stone BV; Tallman JE; Moses KA
    J Urol; 2021 Oct; 206(4):866-872. PubMed ID: 34032493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenal biopsy, as a diagnostic method, is associated with decreased overall survival in patients with T1/T2 adrenocortical carcinoma: A propensity score-matched analysis.
    Naffouje SA; Sabesan A; Hallanger-Johnson J; Kirtane K; Gonzalez RJ; Mullinax J
    J Surg Oncol; 2021 Dec; 124(8):1261-1271. PubMed ID: 34424540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.
    Kwok GTY; Zhao JT; Glover AR; Gill AJ; Clifton-Bligh R; Robinson BG; Ip JCY; Sidhu SB
    Oncologist; 2019 Jun; 24(6):e241-e250. PubMed ID: 30918109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
    Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
    Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study.
    Weigand I; Altieri B; Lacombe AMF; Basile V; Kircher S; Landwehr LS; Schreiner J; Zerbini MCN; Ronchi CL; Megerle F; Berruti A; Canu L; Volante M; Paiva I; Della Casa S; Sbiera S; Fassnacht M; Fragoso MCBV; Terzolo M; Kroiss M
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32449514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Adrenocortical Carcinoma.
    Vaidya A; Nehs M; Kilbridge K
    Surg Pathol Clin; 2019 Dec; 12(4):997-1006. PubMed ID: 31672303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma.
    Kim Y; Margonis GA; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem AI; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
    JAMA Surg; 2016 Apr; 151(4):365-73. PubMed ID: 26676603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenocortical carcinoma.
    Baudin E;
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):411-34. PubMed ID: 26038209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of adrenocortical tumors in children.
    Hanna AM; Pham TH; Askegard-Giesmann JR; Grams JM; Iqbal CW; Stavlo P; Moir CR
    J Pediatr Surg; 2008 May; 43(5):843-9. PubMed ID: 18485950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma.
    Else T; Williams AR; Sabolch A; Jolly S; Miller BS; Hammer GD
    J Clin Endocrinol Metab; 2014 Feb; 99(2):455-61. PubMed ID: 24302750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Laparoscopic Adrenalectomy on Overall Survival in Patients with Nonmetastatic Adrenocortical Carcinoma.
    Huynh KT; Lee DY; Lau BJ; Flaherty DC; Lee J; Goldfarb M
    J Am Coll Surg; 2016 Sep; 223(3):485-92. PubMed ID: 27238874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant radiotherapy after surgical resection for adrenocortical carcinoma: A systematic review of observational studies and meta-analysis.
    Viani GA; Viana BS
    J Cancer Res Ther; 2019 Mar; 15(Supplement):S20-S26. PubMed ID: 30900615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group.
    Poorman CE; Ethun CG; Postlewait LM; Tran TB; Prescott JD; Pawlik TM; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solórzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Staley CA; Poultsides GA; Maithel SK
    Ann Surg Oncol; 2018 Feb; 25(2):520-527. PubMed ID: 29164414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary management of adrenocortical carcinoma.
    Zini L; Porpiglia F; Fassnacht M
    Eur Urol; 2011 Nov; 60(5):1055-65. PubMed ID: 21831516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Management Strategies and Outcomes in Children With Adrenocortical Carcinoma.
    Ziogas IA; Hills-Dunlap JL; Corkum KS; Cost NG; Gosain A; Roach JP
    J Surg Res; 2024 Sep; 301():110-117. PubMed ID: 38925097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenocortical carcinoma surgery-surgical extent and approach.
    Vanbrugghe C; Lowery AJ; Golffier C; Taieb D; Sebag F
    Langenbecks Arch Surg; 2016 Nov; 401(7):991-997. PubMed ID: 27412357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenocortical carcinoma: effect of hospital volume on patient outcome.
    Lombardi CP; Raffaelli M; Boniardi M; De Toma G; Marzano LA; Miccoli P; Minni F; Morino M; Pelizzo MR; Pietrabissa A; Renda A; Valeri A; De Crea C; Bellantone R
    Langenbecks Arch Surg; 2012 Feb; 397(2):201-7. PubMed ID: 22069043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Treatment Practice for Adrenocortical Carcinoma: Have They Changed and Have We Made Any Progress?
    Tierney JF; Chivukula SV; Poirier J; Pappas SG; Schadde E; Hertl M; Kebebew E; Keutgen X
    J Clin Endocrinol Metab; 2019 Dec; 104(12):5948-5956. PubMed ID: 31361313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The underlying molecular mechanism and drugs for treatment in adrenal cortical carcinoma.
    Ma C; Xiong J; Su H; Li H
    Int J Med Sci; 2021; 18(13):3026-3038. PubMed ID: 34220331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.